FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms

The U.S. Food and Drug Administration’s Center for Devices and Radiological Health has issued letters to two third-party medical device testing firms in China.
Source: FDA Press Releases